MENU

YMAB Y-mAbs Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

YMAB is expected to report earnings to fall 27.19% to -11 cents per share on February 20

Y-mAbs Therapeutics YMAB Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.18
The last earnings report on November 08 showed earnings per share of -15 cents, missing the estimate of -15 cents. With 200.69K shares outstanding, the current market capitalization sits at 426.84M.
A.I. Advisor
published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

YMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with RCKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YMAB
1D Price
Change %
YMAB100%
-3.93%
RCKT - YMAB
42%
Loosely correlated
+1.36%
PGEN - YMAB
41%
Loosely correlated
+2.46%
IDYA - YMAB
41%
Loosely correlated
+1.07%
CRSP - YMAB
40%
Loosely correlated
+0.88%
FATE - YMAB
40%
Loosely correlated
-6.00%
More